Abstract:Since the first genome-wide association study on human age-related macular degeneration was reported by Science journal in 2005, a series of genome-wide association studies have been published on human complex diseases or traits, such as obesity, type 2 diabetes, coronary artery disease, Alzheimer's disease and so on. The study of human genetics has recently undergone a dramatic transition which is called "the first wave of genome-wide association study". Some issues in statistical analysis of genome-wide association studies were reviewed by this paper. First, statistical analysis guidelines, methods and examples for genome-wide association studies of different designs, including unrelated case-control studies, population-based studies, and family-based association studies; second, multiple testing correction of P values, including Bonferroni correction, step-down Bonferroni correction, permutation correction, and the correction based on false discovery rate; third, population stratification and its effect on inference of genotype-phenotype associations. The False Positive Re-port Probability has been successfully applied in a recent genome-wide association study on coronary artery disease to con-trol the population stratification. Although genetic statistical methodology has been greatly developed in control of false positive associations caused by multiple testing or population stratification, it is still not sufficient to achieve the goal. Replicating genotype-phenotype associations is the only way to identify true association between genetic markers and common disease traits. The first wave of genome-wide association studies is producing an impressive list of unexpected associations between genes or chromosomal regions and a broad range of diseases. Traditional statistical techniques are adequate for the analysis and interpretation of these results. However, much more sophisticated methods of statistical analysis are likely to be required as we delve further into the genome in the search for networks of interacting gene variants, or interactions be-tween gene-gene networks and environmental factors. Finally, some useful links about statistical software for genome-wide association studies were provided.

Assessing the function of genetic variants in candidate gene association studies

Principles for the Post-Gwas Functional Characterisation of Risk Loci

From variant to function in human disease genetics

Understanding genetic variants in context

DNA-binding factor footprints and enhancer RNAs identify functional non-coding genetic variants

The functional genomics laboratory: functional validation of genetic variants

Genome-wide association studies: theoretical and practical concerns

Incorporating functional annotation information in prioritizing disease associated SNPs from genome wide association studies

Identifying adaptive alleles in the human genome: from selection mapping to functional validation

Optimization Methods for Genotype Data Analysis in Epidemiological Studies

A New Approach for Discovering Functional Links Connecting Non-Coding Regulatory Variants to Gene Targets

Genome-wide association study on complex diseases: genetic statistical issues]

A consensus variant-to-function score to functionally prioritize variants for disease

Meta-Analysis of Gene Level Association Tests

Consultation informs strategies to improve functional evidence use in variant classification

Genomic annotation of disease-associated variants reveals shared functional contexts

In search of causal variants: refining disease association signals using cross-population contrasts

From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases

Genetic associations of protein-coding variants in human disease

Strategies to Identify Pharmacogenomic Biomarkers: Candidate Gene, Pathway-Based, and Genome-Wide Approaches

An Evolutionary Perspective On Single-Nucleotide Polymorphism Screening In Molecular Cancer Epidemiology